Mycophenolate mofetil, a new immunosuppressive agent. Is pharmacokinetic monitoring necessary?;Le mycophenolate mofetil, un nouvel immunosuppresseur. Une surveillance pharmacocinetique est-elle justifiee?

Therapie

Volumn 52, Issue 2, 1997, Pages 139-142

  Barre J ^a   Simon, N ^a   Tillement, J P ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

drug monitoring; immunosuppressive agent; mycophenolate mofetil; mycophenolic acid

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEW DRUG; DRUG DERIVATIVE; MYCOPHENOLIC ACID; PRODRUG;

BLOOD TOXICITY; DRUG BLOOD LEVEL; DRUG MONITORING; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HUMAN; LYMPHATIC SYSTEM DISEASE; PRIORITY JOURNAL; REVIEW; ARTICLE; BLOOD; POSTMARKETING SURVEILLANCE;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PRODRUGS; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0031087887     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Fulton B, Markham A. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 1996; 51: 278-298.
2. Ranson JT. Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995; 17: 681-684.
3. Bullingham R, Monroe S, Nicholls A, Hale M. Pharmacokinetics and bioavailability of mycophenolate mofetil in subjects after single-dose and intravenous administration. J Clin Pharmacol 1996; 36: 315-324.
4. Nowak I, Shaw LM. Mycophenolic acid binding to human serum binding: characterization and relation to pharmacodynamics. Clin Chem 1995; 41: 1011-1017.
5. Shaw LM, Sollinger HW, Halloran P et al. Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit 1995; 17; 690-699.
6. Shaw LM, Nowak I. Mycophenolic acid: measurement and relationship to pharmacologic effects. Ther Drug Monit 1995; 27: 685-689.
7. Takahashi K, Ochial T, Uchida K et al. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. Transplant Proc 1995; 27: 142-144.
8. Langman LJ, Le Gatt DF, Yatscoft RW. Pharmacodynamic assessment of mycophenolic acid induced immuno suppression by measuring IMP deshydrogenase activity. Clin Chem 1995; 41: 295-299.